Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=Person:%22Gandjour%2C+Afschin%22
/vufind/Search/Results?lookfor=Person:%22Gandjour%2C+Afschin%22
Search /vufind/Search2/Results?lookfor=Person:%22Gandjour%2C+Afschin%22
PubPharm (376)
1
The Clinical and Economic Value of a Successful Shutdown During the SARS-CoV-2 Pandemic in Germany
enthalten in:
bioRxiv.org
| 2024
von
Gandjour, A.
Wird geladen...
2
How much reserve capacity is justifiable for hospital pandemic preparedness? A cost-effectiveness analysis for COVID-19 in Germany
enthalten in:
bioRxiv.org
| 2024
von
Gandjour, A.
Wird geladen...
3
The impact of health expenditures on mortality in England : Assessing plausibility
enthalten in:
Health policy (Amsterdam, Netherlands)
| 2024
von
Gandjour, A.
Wird geladen...
4
Value-based pricing of cognitive behavioral therapy for depression in primary care : an economic evaluation
enthalten in:
BMC health services research
| 2024
von
Gandjour, A.
Wird geladen...
5
Comment on : "10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?"
enthalten in:
Applied health economics and health policy
| 2024
von
Gandjour, A.
CommentOn: Appl Health Econ Health Policy. 2023 Sep;21(5):751-759. - PMID 37249741
Wird geladen...
6
Negative Drug Pricing in the Context of Cost-Effectiveness Analysis : A Consistency Examination
enthalten in:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
| 2024
von
Gandjour, A.
Wird geladen...
7
Comment on: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”
enthalten in:
Applied health economics and health policy
| 2023
von
Gandjour, A.
Wird geladen...
8
Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany : a comment
enthalten in:
The European journal of health economics : HEPAC : health economics in prevention and care
| 2023
von
Gandjour, A.
CommentOn: Eur J Health Econ. 2023 Apr;24(3):437-451. - PMID 35708786
Wird geladen...
9
Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany : a comment
enthalten in:
The European journal of health economics
| 2023
von
Gandjour, A.
|
Büssgen, M.
|
Stargardt, T.
Wird geladen...
10
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany
enthalten in:
Applied health economics and health policy
| 2023
von
Gandjour, A.
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[38]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
373
Aufsätze
228
E-Ressourcen
227
E-Artikel
146
Gedruckte Aufsätze
3
Bücher
2
Gedruckte Bücher
2
Hochschulschriften
1
E-Books
Alle anzeigen ...
weniger ...
Zeitschriftentitel
67
PharmacoEconomics
41
Applied health economics and health policy
41
The European journal of health economics
23
BMC health services research
23
Expert review of pharmacoeconomics & outcomes r...
16
Health economics
13
The European journal of health economics : HEPA...
10
Value in health : the journal of the Internatio...
9
Health care management science
8
Value in health
7
JAMA
5
Health services management research
5
International journal of technology assessment ...
4
Archives of internal medicine
4
European journal of nuclear medicine and molecu...
4
Health policy (Amsterdam, Netherlands)
4
Journal of health economics
4
Medical decision making : an international jour...
4
PloS one
3
Medizinische Klinik, Intensivmedizin und Notfal...
Alle anzeigen ...
weniger ...
Thema
103
Journal Article
42
Comment
39
Letter
17
Research Support, Non-U.S. Gov't
15
Germany
12
Cost-effectiveness
11
COVID-19
10
Comparative Study
9
Review
8
Pricing
7
Alendronate
7
Incremental Cost
6
Cancer
6
Economics
6
Pharmaceutical Preparations
6
Proportional Rule
5
AMNOG
5
Angiotensin-Converting Enzyme Inhibitors
5
Bone Mineral Density
5
Cost-effectiveness analysis
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
78
2020-
168
2010-2019
100
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
317
Englisch
9
Deutsch
Haven't found what you're looking for?
Wird geladen...